The effect of advanced glycation endproduct accumulation on bone

Diabetes is associated with increased fracture risk, which leads to increased morbidity and eventual mortality with a substantial financial burden. Type 2 Diabetics also have increased fracture risk, despite having the same or higher BMD as non-diabetics with a low fracture risk. One hypothesis for...

Full description

Bibliographic Details
Main Author: Van Vliet, Miranda
Language:en_US
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/2144/23999
id ndltd-bu.edu-oai-open.bu.edu-2144-23999
record_format oai_dc
spelling ndltd-bu.edu-oai-open.bu.edu-2144-239992019-01-08T15:42:22Z The effect of advanced glycation endproduct accumulation on bone Van Vliet, Miranda Nutrition Advanced glycation endproducts Bone Diabetes Non-enzymatic glycation Reference point indentation Diabetes is associated with increased fracture risk, which leads to increased morbidity and eventual mortality with a substantial financial burden. Type 2 Diabetics also have increased fracture risk, despite having the same or higher BMD as non-diabetics with a low fracture risk. One hypothesis for this is increased modifications made to the extra-cellular matrix via non-enzymatic glycation (NEG) that can occur in a hyperglycemic environment, such as with diabetes. The accumulation of NEG products, known as advanced glycation endproducts (AGEs) can possibly lead to microdamage and eventual weakening of the bone itself. We developed a time-response model in order to induce a wide range of AGEs in a manner that would sustain the mineral integrity of the bone and could be applied to a variety of bone sample types. This was performed on 65 rat tibias, distributed amongst 8 groups (3,7,10, & 14 days) for both ribose and control. Secondly, the protocol was performed on human cortical beam samples cut from 10 donor tibias with 3,5 and 7 day time points for ribose and control groups. All samples were incubated in a 0.6 M ribose solution or 0.0 M ribose control solution. There was a 7, 4, and 5-fold increase in AGEs at the 7, 10, and 14 day time points respectively over controls in the rat tibia study. There was no significant variation in cortical porosity, however TTMD was significantly less dense in the 14-day ribose treated groups. There was a trend toward higher AGEs with time in the human cortical beam specimens, but no significant increase. The AGEs values in the human cortical beam specimens were much lower than expected based on previous trials and reports in the literature. We were able to establish a time-response model for AGE accumulation in bone. However, the effects of AGEs on bone material properties remains inconclusive. 2017-09-25T18:45:08Z 2017-09-25T18:45:08Z 2017 2017-07-13T22:15:37Z Thesis/Dissertation https://hdl.handle.net/2144/23999 en_US
collection NDLTD
language en_US
sources NDLTD
topic Nutrition
Advanced glycation endproducts
Bone
Diabetes
Non-enzymatic glycation
Reference point indentation
spellingShingle Nutrition
Advanced glycation endproducts
Bone
Diabetes
Non-enzymatic glycation
Reference point indentation
Van Vliet, Miranda
The effect of advanced glycation endproduct accumulation on bone
description Diabetes is associated with increased fracture risk, which leads to increased morbidity and eventual mortality with a substantial financial burden. Type 2 Diabetics also have increased fracture risk, despite having the same or higher BMD as non-diabetics with a low fracture risk. One hypothesis for this is increased modifications made to the extra-cellular matrix via non-enzymatic glycation (NEG) that can occur in a hyperglycemic environment, such as with diabetes. The accumulation of NEG products, known as advanced glycation endproducts (AGEs) can possibly lead to microdamage and eventual weakening of the bone itself. We developed a time-response model in order to induce a wide range of AGEs in a manner that would sustain the mineral integrity of the bone and could be applied to a variety of bone sample types. This was performed on 65 rat tibias, distributed amongst 8 groups (3,7,10, & 14 days) for both ribose and control. Secondly, the protocol was performed on human cortical beam samples cut from 10 donor tibias with 3,5 and 7 day time points for ribose and control groups. All samples were incubated in a 0.6 M ribose solution or 0.0 M ribose control solution. There was a 7, 4, and 5-fold increase in AGEs at the 7, 10, and 14 day time points respectively over controls in the rat tibia study. There was no significant variation in cortical porosity, however TTMD was significantly less dense in the 14-day ribose treated groups. There was a trend toward higher AGEs with time in the human cortical beam specimens, but no significant increase. The AGEs values in the human cortical beam specimens were much lower than expected based on previous trials and reports in the literature. We were able to establish a time-response model for AGE accumulation in bone. However, the effects of AGEs on bone material properties remains inconclusive.
author Van Vliet, Miranda
author_facet Van Vliet, Miranda
author_sort Van Vliet, Miranda
title The effect of advanced glycation endproduct accumulation on bone
title_short The effect of advanced glycation endproduct accumulation on bone
title_full The effect of advanced glycation endproduct accumulation on bone
title_fullStr The effect of advanced glycation endproduct accumulation on bone
title_full_unstemmed The effect of advanced glycation endproduct accumulation on bone
title_sort effect of advanced glycation endproduct accumulation on bone
publishDate 2017
url https://hdl.handle.net/2144/23999
work_keys_str_mv AT vanvlietmiranda theeffectofadvancedglycationendproductaccumulationonbone
AT vanvlietmiranda effectofadvancedglycationendproductaccumulationonbone
_version_ 1718812403721830400